Clinical pulmonary involvement in primary Sjögren's syndrome: Prevalence, quality of life and mortality - A retrospective study based on registry data

Rheumatology (United Kingdom)

Volumn 52, Issue 1, 2013, Pages 173-179

  Palm, Øyvind ^a   Garen, Torhild ^a   Enger, Tone Berge ^b   Jensen, Janicke Liaaen ^b   Lund, May Brit ^a,b   AalØkken, Trond Mogens ^a   Gran, Jan Tore ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Computed tomography; Mortality; Population register; Pulmonary disease; Quality of life; Sj gren's syndrome

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT REFERRAL; PREVALENCE; PRIMARY SJOEGREN SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; REGISTER; RETROSPECTIVE STUDY; SHORT FORM 36; SJOEGREN SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; NORWAY; PREVALENCE; QUALITY OF LIFE; REGISTRIES; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME; SURVIVAL ANALYSIS;

EID: 84871105758     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes311     Document Type: Article

References (35)

1. Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA. Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982-2003. Rheumatology 2006;45:187-91.
2. Goransson LG, Haldorsen K, Brun JG et al. The point prevalence of clinically relevant primary Sjogren's syndrome in two Norwegian counties. Scand J Rheumatol 2011;40:221-4.
3. Haugen AJ, Peen E, Hulten B et al. Estimation of the prevalence of primary Sjogren's syndrome in two age-different community-based populations using two sets of classification criteria: the Hordaland Health Study. Scand J Rheumatol 2008;37:30-4.
4. Tzioufas AG, Voulgarelis M. Update on Sjogren's syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 2007;21:989-1010.
5. Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study. Arthritis Rheum 2004;50:1262-9.
6. Strimlan CV, Rosenow EC III, Divertie MB, Harrison EG Jr. Pulmonary manifestations of Sjogren's syndrome. Chest 1976;70:354-61.
7. Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM. Respiratory manifestations in primary Sjogren's syndrome. A clinical, functional, and histologic study. Chest 1985;88:226-9.
8. Wright SA, Convery RP, Liggett N. Pulmonary involvement in Sjogren's syndrome. Rheumatology 2003;42:697-8.
9. Yazisiz V, Arslan G, Ozbudak IH et al. Lung involvement in patients with primary Sjogren's syndrome: what are the predictors? Rheumatol Int 2010;30:1317-24.
10. Kokosi M, Riemer EC, Highland KB. Pulmonary involvement in Sjogren syndrome. Clin Chest Med 2010;31: 489-500.
11. Uffmann M, Kiener HP, Bankier AA, Baldt MM, Zontsich T, Herold CJ. Lung manifestation in asymptomatic patients with primary Sjogren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imag 2001;16:282-9.
12. Lin DF, Yan SM, Zhao Y et al. Clinical and prognostic characteristics of 573 cases of primary Sjogren's syndrome. Chin Med J 2010;123:3252-7.
13. Franquet T, Gimenez A, Monill JM, Diaz C, Geli C. Primary Sjogren's syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol 1997;169: 655-8.
14. Davidson BK, Kelly CA, Griffiths ID. Ten year follow up of pulmonary function in patients with primary Sjogren's syndrome. Ann Rheum Dis 2000;59:709-12.
15. Ito I, Nagai S, Kitaichi M et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 2005;171: 632-8.
16. Baturone R, Soto MJ, Marquez M et al. Health-related quality of life in patients with primary Sjogren's syndrome: relationship with serum levels of proinflammatory cytokines. Scand J Rheumatol 2009;38:386-9.
17. Belenguer R, Ramos-Casals M, Brito-Zeron P et al. Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjogren's syndrome. Clin Exp Rheumatol 2005;23:351-6.
18. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
19. Watanabe M, Naniwa T, Hara M, Arakawa T, Maeda T. Pulmonary manifestations in Sjogren's syndrome: correlation analysis between chest computed tomographic findings and clinical subsets with poor prognosis in 80 patients. J Rheumatol 2010;37:365-73.
20. Lazor R. Lung involvement in Sjogren's syndrome: interstitium, airways, or both? Respiration 2009;78:375-6.
21. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
22. Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC. [Standardization of the measurement of transfer factor (diffusing capacity). Work Group on Standardization of Respiratory Function Tests. European Community for Coal and Steel. Official position of the European Respiratory Society]. Rev Mal Respir 1994;11(SUPPL. 3):41-52.
23. Ware JE Jr. SF-36 health survey update. Spine 2000;25: 3130-9.
24. Enger TB, Palm O, Garen T, Sandvik L, Jensen JL. Oral distress in primary Sjogren's syndrome: implications for health-related quality of life. Eur J Oral Sci 2011;119: 474-80.
25. Ramos-Casals M, Solans R, Rosas J et al. Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine 2008;87:210-9.
26. Vitali C, Bombardieri S, Moutsopoulos HM et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
27. Meijer JM, Meiners PM, Vissink A et al. Effectiveness of rituximab treatment in primary Sjogren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010;62:960-8.
28. Seror R, Sordet C, Guillevin L et al. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndrome. Ann Rheum Dis 2007;66:351-7.
29. Kelly C, Gardiner P, Pal B, Griffiths I. Lung function in primary Sjogren's syndrome: a cross sectional and longitudinal study. Thorax 1991;46:180-3.
30. Seror R, Ravaud P, Bowman SJ et al. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 2010;69:1103-9.
31. Koenig SM. Pulmonary complications of obesity. Am J Med Sci 2001;321:249-79.
32. Perrin C, Unterborn JN, Ambrosio CD, Hill NS. Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve 2004;29:5-27.
33. Deheinzelin D, Capelozzi VL, Kairalla RA, Barbas Filho JV, Saldiva PH, de Carvalho CR. Interstitial lung disease in primary Sjogren's syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 1996;154:794-9.
34. Ishii M, Uda H, Yamagami T, Katada Y. Possible association of 'shrinking lung' and anti-Ro/SSA antibody. Arthritis Rheum 2000;43:2612-3.
35. La Corte R, Lo Monaco A, Locaputo A, Dolzani F, Trotta F. patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease. Autoimmunity 2006;39:249-53.